256 related articles for article (PubMed ID: 37131219)
1. Location and condition based reconstruction of colon cancer microbiome from human RNA sequencing data.
Sambruni G; Macandog AD; Wirbel J; Cagnina D; Catozzi C; Dallavilla T; Borgo F; Fazio N; Fumagalli-Romario U; Petz WL; Manzo T; Ravenda SP; Zeller G; Nezi L; Schaefer MH
Genome Med; 2023 May; 15(1):32. PubMed ID: 37131219
[TBL] [Abstract][Full Text] [Related]
2. Characterizing the cancer-associated microbiome with small RNA sequencing data.
Lee WH; Chen KP; Wang K; Huang HC; Juan HF
Biochem Biophys Res Commun; 2020 Feb; 522(3):776-782. PubMed ID: 31791588
[TBL] [Abstract][Full Text] [Related]
3. MinION Sequencing of colorectal cancer tumour microbiomes-A comparison with amplicon-based and RNA-Sequencing.
Taylor WS; Pearson J; Miller A; Schmeier S; Frizelle FA; Purcell RV
PLoS One; 2020; 15(5):e0233170. PubMed ID: 32433701
[TBL] [Abstract][Full Text] [Related]
4. Small RNA expression from viruses, bacteria and human miRNAs in colon cancer tissue and its association with microsatellite instability and tumor location.
Mjelle R; Sjursen W; Thommesen L; Sætrom P; Hofsli E
BMC Cancer; 2019 Feb; 19(1):161. PubMed ID: 30786859
[TBL] [Abstract][Full Text] [Related]
5. Quantitative profiling of colorectal cancer-associated bacteria reveals associations between fusobacterium spp., enterotoxigenic Bacteroides fragilis (ETBF) and clinicopathological features of colorectal cancer.
Viljoen KS; Dakshinamurthy A; Goldberg P; Blackburn JM
PLoS One; 2015; 10(3):e0119462. PubMed ID: 25751261
[TBL] [Abstract][Full Text] [Related]
6. First steps towards combining faecal immunochemical testing with the gut microbiome in colorectal cancer screening.
Grobbee EJ; Lam SY; Fuhler GM; Blakaj B; Konstantinov SR; Bruno MJ; Peppelenbosch MP; Kuipers EJ; Spaander MC
United European Gastroenterol J; 2020 Apr; 8(3):293-302. PubMed ID: 32213018
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiome associated with APC gene mutation in patients with intestinal adenomatous polyps.
Liang S; Mao Y; Liao M; Xu Y; Chen Y; Huang X; Wei C; Wu C; Wang Q; Pan X; Tang W
Int J Biol Sci; 2020; 16(1):135-146. PubMed ID: 31892851
[No Abstract] [Full Text] [Related]
8. The gut microbiota composition in patients with right- and left-sided colorectal cancer and after curative colectomy, as analyzed by 16S rRNA gene amplicon sequencing.
Suga D; Mizutani H; Fukui S; Kobayashi M; Shimada Y; Nakazawa Y; Nishiura Y; Kawasaki Y; Moritani I; Yamanaka Y; Inoue H; Ojima E; Mohri Y; Nakagawa H; Dohi K; Takaba K; Wada H; Shiraki K
BMC Gastroenterol; 2022 Jun; 22(1):313. PubMed ID: 35752764
[TBL] [Abstract][Full Text] [Related]
9. Tumour-associated and non-tumour-associated microbiota: Addendum.
Flemer B; Herlihy M; O'Riordain M; Shanahan F; O'Toole PW
Gut Microbes; 2018 Jul; 9(4):369-373. PubMed ID: 29420132
[TBL] [Abstract][Full Text] [Related]
10. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
11. The influence of blood on the human gut microbiome.
Chénard T; Malick M; Dubé J; Massé E
BMC Microbiol; 2020 Mar; 20(1):44. PubMed ID: 32126968
[TBL] [Abstract][Full Text] [Related]
12. Crypt- and Mucosa-Associated Core Microbiotas in Humans and Their Alteration in Colon Cancer Patients.
Saffarian A; Mulet C; Regnault B; Amiot A; Tran-Van-Nhieu J; Ravel J; Sobhani I; Sansonetti PJ; Pédron T
mBio; 2019 Jul; 10(4):. PubMed ID: 31311881
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral microbiome is driven by metastatic site and associated with immune histopathological parameters: An ancillary study of the SHIVA clinical trial.
Hilmi M; Kamal M; Vacher S; Dupain C; Ibadioune S; Halladjian M; Sablin MP; Marret G; Ajgal ZC; Nijnikoff M; Salomon A; El Beaino Z; Servant N; Dureau S; Sokol H; Nicolle R; Le Tourneau C; Bieche I; Neuzillet C
Eur J Cancer; 2023 Apr; 183():152-161. PubMed ID: 36868056
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiota composition in colorectal cancer patients is genetically regulated.
Colombo F; Illescas O; Noci S; Minnai F; Pintarelli G; Pettinicchio A; Vannelli A; Sorrentino L; Battaglia L; Cosimelli M; Dragani TA; Gariboldi M
Sci Rep; 2022 Jul; 12(1):11424. PubMed ID: 35794137
[TBL] [Abstract][Full Text] [Related]
15. Parvimonas micra is associated with tumour immune profiles in molecular subtypes of colorectal cancer.
Löwenmark T; Li X; Löfgren-Burström A; Zingmark C; Ling A; Kellgren TG; Larsson P; Ljuslinder I; Wai SN; Edin S; Palmqvist R
Cancer Immunol Immunother; 2022 Oct; 71(10):2565-2575. PubMed ID: 35301576
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic cyst fluid harbors a unique microbiome.
Li S; Fuhler GM; Bn N; Jose T; Bruno MJ; Peppelenbosch MP; Konstantinov SR
Microbiome; 2017 Nov; 5(1):147. PubMed ID: 29122007
[TBL] [Abstract][Full Text] [Related]
17. Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model.
Wu N; Feng YQ; Lyu N; Wang D; Yu WD; Hu YF
World J Gastroenterol; 2022 May; 28(18):1981-1995. PubMed ID: 35664967
[TBL] [Abstract][Full Text] [Related]
18. Identifying important microbial and genomic biomarkers for differentiating right- versus left-sided colorectal cancer using random forest models.
Kolisnik T; Sulit AK; Schmeier S; Frizelle F; Purcell R; Smith A; Silander O
BMC Cancer; 2023 Jul; 23(1):647. PubMed ID: 37434131
[TBL] [Abstract][Full Text] [Related]
19. Integrating bulk and single-cell RNA sequencing data reveals the relationship between intratumor microbiome signature and host metabolic heterogeneity in breast cancer.
Chen F; Yang J; Guo Y; Su D; Sheng Y; Wu Y
Front Immunol; 2023; 14():1140995. PubMed ID: 36999009
[TBL] [Abstract][Full Text] [Related]
20. Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes.
Stintzing S; Tejpar S; Gibbs P; Thiebach L; Lenz HJ
Eur J Cancer; 2017 Oct; 84():69-80. PubMed ID: 28787661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
